CCI 007

CAS No. 939228-52-1

CCI 007( —— )

Catalog No. M24990 CAS No. 939228-52-1

CCI 007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 81 In Stock
5MG 125 In Stock
10MG 200 In Stock
25MG 394 In Stock
50MG 584 In Stock
100MG 833 In Stock
500MG 1683 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    CCI 007
  • Note
    Research use only, not for human use.
  • Brief Description
    CCI 007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485
  • Description
    CCI 007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia with IC50 of 3.5 uM against MLL-r leukemia cell line PER-485
  • In Vitro
    CCI-007 is a selective inhibitor of MLL-r, CALM-AF10 and SET-NUP214 leukemia.Following CCI-007 treatment for 24h, significant mitochondrial depolarization was observed in PER-485 cells as evidenced by a shift in JC-1 signal. CCI-007 alters the characteristic MLL-r gene expression signature in sensitive cells with downregulation of the expression of HOXA9, MEIS1, CMYC and BCL2.Resistance to CCI-007 can occur by upregulation of MLL target gene expression. :Cell Viability Assay Cell Line:PER-485, MOLM-13, MV4;11 cells.Concentration:5 μM.Incubation Time:24 h.Result:Induced apoptosis.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    Histone Demethylase
  • Recptor
    MLL-r
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    939228-52-1
  • Formula Weight
    336.36
  • Molecular Formula
    C15H16N2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    O=C(OCC)COC(C=CC(C=C1SC(N)=NC1=O)=C2)=C2OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Somers K , Chudakova D A , Middlemiss S , et al. CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements[J]. Oncotarget, 2016, 7(29):46067-46087.
molnova catalog
related products
  • KDM5-C49

    KDM5-C49 is a potent, selective KDM5 inhibitor with IC50 of 25, 30 and 59 nM for KDM5A, B and C, respectively.

  • FB23-2

    FB23-2 is a potent, selective inhibitor of the mRNA N 6-methyladenosine (m 6A) demethylase FTO.

  • GSK 690

    GSK 690 is an irreversible, mechanism based inhibitor of lysine specific demethylase 1 (LSD1) with IC50 of 77 uM.